Drug class
Mucolytic; prodrug with thiol-containing active metabolite
Mechanism of action
Erdosteine is a prodrug. First-pass metabolism releases free thiol groups that open disulphide bonds in bronchial mucoproteins, reducing mucus viscosity. The active metabolite also has antioxidant activity and can inhibit bacterial adhesion to epithelial cells.
General use cases
- Expectorant and symptomatic treatment of acute exacerbations of chronic bronchitis in adults under the cited UK SmPC; other national product information may include additional acute/chronic respiratory conditions with excessive mucus
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
